These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38837701)

  • 21. Difficult to treat rheumatoid arthritis in a comprehensive evaluation program: frequency according to different objective evaluations.
    Garcia-Salinas R; Sanchez-Prado E; Mareco J; Ronald P; Ruta S; Gomez R; Magri S
    Rheumatol Int; 2023 Oct; 43(10):1821-1828. PubMed ID: 37269430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Five-year follow-up of patients with difficult-to-treat rheumatoid arthritis.
    Takanashi S; Takeuchi T; Kaneko Y
    Rheumatology (Oxford); 2024 Jun; ():. PubMed ID: 38851883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and ultrasound features of difficult-to-treat rheumatoid arthritis: A multicenter RA ultrasound cohort study.
    Michitsuji T; Fukui S; Morimoto S; Endo Y; Nishino A; Nishihata S; Tsuji Y; Shimizu T; Umeda M; Sumiyoshi R; Koga T; Iwamoto N; Origuchi T; Ueki Y; Yoshitama T; Eiraku N; Matsuoka N; Okada A; Fujikawa K; Ohtsubo H; Takaoka H; Hamada H; Tsuru T; Nawata M; Arinobu Y; Hidaka T; Tada Y; Kawakami A; Kawashiri SY
    Scand J Rheumatol; 2024 Mar; 53(2):123-129. PubMed ID: 38085537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Characteristics of Potential "Difficult-to-treat" Patients with Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort.
    Perrotta FM; Scriffignano S; Ciccia F; Lubrano E
    Rheumatol Ther; 2022 Aug; 9(4):1193-1201. PubMed ID: 35612694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poly-Refractory Rheumatoid Arthritis: An Uncommon Subset of Difficult to Treat Disease With Distinct Inflammatory and Noninflammatory Phenotypes.
    David P; Di Matteo A; Hen O; Dass S; Marzo-Ortega H; Wakefield RJ; Bissell LA; Nam J; Mankia K; Emery P; Saleem B; McGonagle D
    Arthritis Rheumatol; 2024 Apr; 76(4):510-521. PubMed ID: 38059326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical characteristics and variants that predict prognosis of difficult-to-treat rheumatoid arthritis.
    Yoshii I; Sawada N; Chijiwa T
    Rheumatol Int; 2022 Nov; 42(11):1947-1954. PubMed ID: 35410410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of Janus kinase inhibitors in patients with difficult-to-treat rheumatoid arthritis.
    Anno S; Okano T; Mamoto K; Yamada Y; Mandai K; Orita K; Iida T; Tada M; Inui K; Koike T; Nakamura H
    Mod Rheumatol; 2024 Aug; ():. PubMed ID: 39215592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inappropriate treatment response to DMARDs: A pathway to difficult-to-treat rheumatoid arthritis.
    Guo H; Li L; Liu B; Lu P; Cao Z; Ji X; Li L; Ouyang G; Nie Z; Lyu A; Lu C
    Int Immunopharmacol; 2023 Sep; 122():110655. PubMed ID: 37481847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic issues in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis.
    Roodenrijs NMT; Kedves M; Hamar A; Nagy G; van Laar JM; van der Heijde D; Welsing PMJ
    RMD Open; 2021 Jan; 7(1):. PubMed ID: 33514671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and predictive factors of difficult-to-treat rheumatoid arthritis: the KURAMA cohort.
    Watanabe R; Hashimoto M; Murata K; Murakami K; Tanaka M; Ohmura K; Ito H; Matsuda S
    Immunol Med; 2022 Mar; 45(1):35-44. PubMed ID: 34033729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of patients with difficult-to-treat rheumatoid arthritis in clinical practice.
    Takanashi S; Kaneko Y; Takeuchi T
    Rheumatology (Oxford); 2021 Nov; 60(11):5247-5256. PubMed ID: 33682890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EULAR definition of difficult-to-treat rheumatoid arthritis.
    Nagy G; Roodenrijs NMT; Welsing PM; Kedves M; Hamar A; van der Goes MC; Kent A; Bakkers M; Blaas E; Senolt L; Szekanecz Z; Choy E; Dougados M; Jacobs JW; Geenen R; Bijlsma HW; Zink A; Aletaha D; Schoneveld L; van Riel P; Gutermann L; Prior Y; Nikiphorou E; Ferraccioli G; Schett G; Hyrich KL; Mueller-Ladner U; Buch MH; McInnes IB; van der Heijde D; van Laar JM
    Ann Rheum Dis; 2021 Jan; 80(1):31-35. PubMed ID: 33004335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis.
    Nagy G; Roodenrijs NMT; Welsing PMJ; Kedves M; Hamar A; van der Goes MC; Kent A; Bakkers M; Pchelnikova P; Blaas E; Senolt L; Szekanecz Z; Choy EH; Dougados M; Jacobs JW; Geenen R; Bijlsma JW; Zink A; Aletaha D; Schoneveld L; van Riel P; Dumas S; Prior Y; Nikiphorou E; Ferraccioli G; Schett G; Hyrich KL; Mueller-Ladner U; Buch MH; McInnes IB; van der Heijde D; van Laar JM
    Ann Rheum Dis; 2022 Jan; 81(1):20-33. PubMed ID: 34407926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of comorbidities differentially affect long-term functional evolution and disease activity in patients with 'difficult to treat' rheumatoid arthritis.
    Bertsias A; Flouri ID; Repa A; Avgoustidis N; Kalogiannaki E; Pitsigavdaki S; Bertsias G; Sidiropoulos P
    RMD Open; 2024 Jan; 10(1):. PubMed ID: 38242549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update.
    Smolen JS; Landewé R; Bijlsma J; Burmester G; Chatzidionysiou K; Dougados M; Nam J; Ramiro S; Voshaar M; van Vollenhoven R; Aletaha D; Aringer M; Boers M; Buckley CD; Buttgereit F; Bykerk V; Cardiel M; Combe B; Cutolo M; van Eijk-Hustings Y; Emery P; Finckh A; Gabay C; Gomez-Reino J; Gossec L; Gottenberg JE; Hazes JMW; Huizinga T; Jani M; Karateev D; Kouloumas M; Kvien T; Li Z; Mariette X; McInnes I; Mysler E; Nash P; Pavelka K; Poór G; Richez C; van Riel P; Rubbert-Roth A; Saag K; da Silva J; Stamm T; Takeuchi T; Westhovens R; de Wit M; van der Heijde D
    Ann Rheum Dis; 2017 Jun; 76(6):960-977. PubMed ID: 28264816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics of difficult-to-treat axial spondyloarthritis: Results of a real-world multicentric study.
    Philippoteaux C; Delepine T; Cailliau E; Philippe P; Taisne N; Pascart T; Cortet B; Paccou J; Flipo RM; Letarouilly JG
    Joint Bone Spine; 2024 Mar; 91(2):105670. PubMed ID: 38036061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comorbidities and extra-articular manifestations in difficult-to-treat rheumatoid arthritis: different sides of the same coin?
    Dey M; Nagy G; Nikiphorou E
    Rheumatology (Oxford); 2023 May; 62(5):1773-1779. PubMed ID: 36205537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms underlying DMARD inefficacy in difficult-to-treat rheumatoid arthritis: a narrative review with systematic literature search.
    Roodenrijs NMT; Welsing PMJ; van Roon J; Schoneveld JLM; van der Goes MC; Nagy G; Townsend MJ; van Laar JM
    Rheumatology (Oxford); 2022 Aug; 61(9):3552-3566. PubMed ID: 35238332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis.
    Kerschbaumer A; Sepriano A; Smolen JS; van der Heijde D; Dougados M; van Vollenhoven R; McInnes IB; Bijlsma JWJ; Burmester GR; de Wit M; Falzon L; Landewé R
    Ann Rheum Dis; 2020 Jun; 79(6):744-759. PubMed ID: 32033937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adherence of Italian rheumatologists to the EULAR recommendations and outcomes in early rheumatoid arthritis patients after starting conventional DMARDs: Methotrexate in Italian patients wiTh Rheumatoid Arthritis (the MITRA study). A cohort study of the Italian Society for Rheumatology.
    Fornaro M; Benaglio F; Montecucco C; Raffeiner B; Di Franco M; Iannuccelli C; Conigliaro P; Lomater C; Govoni M; Silvagni E; Zanetti A; Parisi S; Carrara G; Scirè CA; Caporali R; Iannone F
    Clin Exp Rheumatol; 2022 Sep; 40(9):1693-1700. PubMed ID: 35084309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.